IMC-010

N/A

Report date: 2026/04/07 20:00:20

First In Class

Base Information

Drug NameIMC-010

Drug Alias NameIMC-010IMM-7220

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Activin receptor type-2AAnti-Glucagon-like peptide 1 receptor

TargetsActivin receptor type-2AGlucagon-like peptide 1 receptor

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsObesity

Inactive IndicationsN/A

Other Information

ATC CodeN/A